Presence or Absence of Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease is Associated With Distinct Phenotypes

被引:15
|
作者
Cruthirds, Clayton L. [1 ]
van der Meij, Barbara S. [1 ,2 ,3 ,4 ]
Wierzchowska-McNew, Agata [1 ]
Deutz, Nicolaas E. P. [1 ]
Engelen, Marielle P. K. J. [1 ]
机构
[1] Texas A&M Univ, Ctr Translat Res Aging & Longev, Dept Hlth & Kinesiol, College Stn, TX 77843 USA
[2] Bond Univ, Nutr & Dietet Res Grp, Fac Hlth Sci & Med, Gold Coast, Qld, Australia
[3] Mater Grp, Dietet & Foodserv, Brisbane, Qld, Australia
[4] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2021年 / 57卷 / 04期
关键词
COPD; Muscle strength; Cognition; Phenotype; Metabolism; COGNITIVE FUNCTION; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS; STRENGTH; REHABILITATION; IMPAIRMENT; METABOLISM; EXERCISE; DECLINE; UPDATE;
D O I
10.1016/j.arbres.2019.12.034
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Reduced skeletal muscle function and cognitive performance are common extrapulmonary features in Chronic Obstructive Pulmonary Disease (COPD) but their connection remains unclear. Whether presence or absence of skeletal muscle dysfunction in COPD patients is linked to a specific phenotype consisting of reduced cognitive performance, comorbidities and nutritional and metabolic disturbances needs further investigation. Methods: Thirty-seven patients with COPD (grade II-IV) were divided into two phenotypic cohorts based on the presence (COPD dysfunctional, n = 25) or absence (COPD functional, n = 12) of muscle dysfunction. These cohorts were compared to 28 healthy, age matched controls. Muscle strength (dynamometry), cognitive performance (Trail Making Test and STROOP Test), body composition (Dual-energy X-Ray Absorptiometry), habitual physical activity, comorbidities and mood status (questionnaires) were measured. Pulse administration of stable amino acid tracers was performed to measure whole body production rates. Results: Presence of muscle dysfunction in COPD was independent of muscle mass or severity of airflow obstruction but associated with impaired STROOP Test performance (p = 0.04), reduced resting O-2 saturation (p = 0.003) and physical inactivity (p = 0.01), and specific amino acid metabolic disturbances (enhanced leucine (p = 0.02) and arginine (p = 0.06) production). In contrast, COPD patients with normal muscle function presented with anxiety, increased fat mass, plasma glucose concentration, and metabolic syndrome related comorbidities (hypertension and dyslipidemia). Conclusion: COPD patients with muscle dysfunction show characteristics of a cognitive metabolic impairment phenotype, influenced by the presence of hypoxia, whereas those with normal muscle function present a phenotype of metabolic syndrome and mood disturbances. (C) 2020 SEPAR. Published by Elsevier Espanna, S.L.U. All rights reserved.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 50 条
  • [21] The Search for Distinct and Clinically Useful Phenotypes in Chronic Obstructive Pulmonary Disease
    Dirksen, Asger
    MacNee, William
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (09) : 1045 - 1046
  • [22] Mitochondrial Quality Control: A New Perspective in Skeletal Muscle Dysfunction of Chronic Obstructive Pulmonary Disease
    Song, Yanxia
    Han, Xiaoyu
    Wang, Yingqi
    Li, Kangxia
    Li, Huanping
    Tian, Yizhu
    Ma, Xiaoqing
    Wu, Weibing
    Wang, Jihong
    AGING AND DISEASE, 2025,
  • [23] Revisiting Skeletal Muscle Dysfunction and Exercise in Chronic Obstructive Pulmonary Disease: Emerging Significance of Myokines
    Han, Lihua
    Li, Peijun
    He, Qinglan
    Yang, Chen
    Jiang, Meiling
    Wang, Yingqi
    Cao, Yuanyuan
    Han, Xiaoyu
    Liu, Xiaodan
    Wu, Weibing
    AGING AND DISEASE, 2024, 15 (06): : 2453 - 2469
  • [24] Acute Respiratory Exacerbations Are Associated with Skeletal Muscle Loss in Chronic Obstructive Pulmonary Disease
    Mason, S.
    Estepar, R. San Jose
    Moreta-Martinez, R.
    Dransfield, M. T.
    Regan, E. A.
    Strand, M. J.
    Washko, G. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] Plasma Sphingolipids Associated with Chronic Obstructive Pulmonary Disease Phenotypes
    Bowler, Russell P.
    Jacobson, Sean
    Cruickshank, Charmion
    Hughes, Grant J.
    Siska, Charlotte
    Ory, Daniel S.
    Petrache, Irina
    Schaffer, Jean E.
    Reisdorph, Nichole
    Kechris, Katerina
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (03) : 275 - 284
  • [26] Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
    Gosker, HR
    Wouters, EFM
    van der Vusse, GJ
    Schols, AMWJ
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (05): : 1033 - 1047
  • [27] PHENOTYPES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Lee, Sang-Do
    RESPIROLOGY, 2010, 15 : 23 - 23
  • [28] The phenotypes of chronic obstructive pulmonary disease
    Mathioudakis, A. G.
    Mathioudakis, G. A.
    ARCHIVES OF HELLENIC MEDICINE, 2014, 31 (05): : 558 - 569
  • [29] Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: Latest Developments
    Gea, Joaquim
    Martinez-Llorens, Juana
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (05): : 237 - 238
  • [30] Clinical consequences of muscle dysfunction in chronic obstructive pulmonary disease
    Sauleda Roig, J.
    NUTRICION HOSPITALARIA, 2006, 21 : 69 - 75